Key Takeaways UNH shares rose 4% post mixed Q4 results, with EPS beating estimates and revenues missing expectations.UnitedHealth expects a 2026 medical care ratio near 88.8%, reflecting improved cost control versus last year.UnitedHealth projects a 21% cut in 2026 Medicaid membership, raising margin concerns. Shares of UnitedHealth Group Incorporated (UNH) rose 4% during the last trading session at the bourses, following its mixed fourth-quarter 2025 results on Jan. 27, 2026. Higher-than-expected operating ...

Core Insights - Humana (HUM) has outperformed the broader Healthcare sector in 2023, exceeding the 2% total return of the iShares U.S. Healthcare Providers ETF (IHF) [1] Company Performance - Shares of Humana, a Managed Healthcare-industry company, have traded lower despite its strong performance relative to the sector [1]

Core Insights - UnitedHealth Group reported better-than-expected third-quarter 2025 earnings with an adjusted EPS of $2.92, exceeding the Zacks Consensus Estimate by 6.2%, but missed revenue expectations by 0.2% [4] - Year-over-year performance showed a decline in earnings by 59.2%, while revenues increased by 12% [4] - The company expects adjusted EPS of at least $16.25 for 2025, up from a previous estimate of $16, and plans to resume share buybacks and strategic acquisitions next year [7] Financial Performance - UnitedHealth's revenues for the third quarter reached $87.1 billion, a 16% increase, while Optum's revenues grew by 8% to $69.2 billion [6] - The company expanded its domestic membership by over 780,000 lives year-to-date, totaling over 50 million members [5] - Cash and short-term investments rose to $30.6 billion from $29.1 billion at the end of 2024, but operating cash flows declined to $18.6 billion from $21.8 billion in the prior year [6] Market Outlook - Investors are encouraged to monitor ETFs with significant exposure to UnitedHealth, including iShares U.S. Healthcare Providers ETF, Health Care Select Sector SPDR Fund, iShares U.S. Healthcare ETF, Vanguard Health Care ETF, and Fidelity MSCI Health Care Index ETF [2][8][9][11][12][13] - These ETFs have shown positive year-to-date performance, with gains ranging from 6.8% to 8.4% [8][9][11][12][13]

Core Viewpoint - UnitedHealth Group (UNH) stock has experienced a significant decline of 40% year-to-date but has rebounded over 20% this month due to investments from notable hedge fund managers, including Warren Buffett's Berkshire Hathaway [1]. Group 1: Investment Activity - Warren Buffett's investment in UnitedHealth Group reflects a classic value investing strategy, indicating his belief in the long-term value of the company, similar to past investments during market crises [2]. - Other billionaire hedge fund managers, such as David Tepper's Appaloosa Management, have also taken stakes in UnitedHealth, suggesting a broader institutional interest [1]. Group 2: Financial Performance and Valuation - UnitedHealth Group's stock has recently approached a decade low in terms of price to forward earnings, aligning with its 10-year forward P/E median of 18X [4]. - The company trades at less than 1X sales and possesses significant cash reserves of over $32 billion, with total assets exceeding $308 billion against total liabilities of $208.1 billion, which may attract large investors [5]. Group 3: Earnings Estimates - UnitedHealth Group has reinstated its guidance, but the expected full-year fiscal 2025 EPS has been revised down to at least $16 per share, with the Zacks Consensus currently at $16.58, reflecting a 25% decline from earlier expectations of $22.28 [8]. - EPS estimates for fiscal year 2026 have also dropped nearly 30% in the last two months, from projections of $25.58 to $18.08, raising concerns among investors [8]. Group 4: Market Sentiment - The influx of institutional investment may have created a psychological floor for UNH stock, but the trend of declining EPS revisions could indicate that better buying opportunities may arise in the future [9]. - Currently, UNH holds a Zacks Rank 5 (Strong Sell), suggesting caution for potential investors [9].

Core Insights - UnitedHealth Group (UNH) reported disappointing first-quarter 2025 results, missing both earnings and revenue estimates, and lowered its full-year guidance due to rising medical costs, leading to a significant decline in its stock price [1][2] - The company's shares fell 22.4% following the results, marking the worst daily decline since 1998 and erasing approximately $120 billion from its market capitalization, although this decline may present a long-term buying opportunity [2] Earnings Performance - Earnings per share (EPS) were reported at $7.20, missing the Zacks Consensus Estimate of $7.27 but showing a 4.2% increase from the previous year's EPS of $6.16 [4] - Revenues grew by 9.8% year-over-year to $109.6 billion, falling short of the estimated $111.1 billion [4] - Optum revenues increased by 4.6% to $63.9 billion, while the medical ratio rose by 0.5 percentage points year-over-year to 84.8%, with management forecasting a ratio of 87%-88% for 2025 [4][6] Consumer Growth - The number of consumers served with self-funded commercial benefits increased by approximately 700,000 in the first quarter, and the number of seniors and complex needs patients served grew by 545,000, expected to reach 800,000 in 2025 [5] - The company's state-based community plans now serve 7.6 million members, and Optum Health anticipates serving 650,000 new value-based care patients in 2025 [5] Guidance Adjustments - UnitedHealth reaffirmed its revenue guidance for 2025 at $450-$455 billion but reduced its EPS guidance to $26.00-$26.50 from a previous range of $29.50-$30.00, citing increased care activity in Medicare Advantage and impacts from Medicare funding reductions [6] ETF Opportunities - Investors may consider ETFs with significant allocations to UnitedHealth, including iShares U.S. Healthcare Providers ETF (IHF), Health Care Select Sector SPDR Fund (XLV), JPMorgan Healthcare Leaders ETF (JDOC), Fidelity MSCI Health Care Index ETF (FHLC), and iShares U.S. Healthcare ETF (IYH) [3]